Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis.
- Author:
Zhongliang LIU
;
Weirong ZHU
;
Wenchao ZHOU
;
Haifeng YING
;
Lan ZHENG
;
Yuanbiao GUO
;
Jingxian CHEN
;
Xiaoheng SHEN
- Publication Type:Journal Article
- From:
Journal of Integrative Medicine
2014;12(4):346-58
- CountryChina
- Language:English
-
Abstract:
Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) targeted treatment has been a standard therapy for advanced non-small cell lung cancer (NSCLC), but it is not tolerated well by all patients. In China, some studies have reported that traditional Chinese medicinal herbs (TCMHs) may increase efficacy and reduce toxicity when combined with EGFR-TKI, but outside of China few studies of this kind have been attempted.
